LY 233053

Names

[ CAS No. ]:
125546-04-5

[ Name ]:
LY 233053

Biological Activity

[Description]:

LY 233053 is a potent and competitive NMDA-receptor antagonist with anticonvulsant and antiepileptic efficacy[1][2].

[Related Catalog]:

Signaling Pathways >> Neuronal Signaling >> iGluR

Research Areas >> Inflammation/Immunology

Research Areas >> Neurological Disease

Signaling Pathways >> Membrane Transporter/Ion Channel >> iGluR

[Target]

NMDA Receptor

[In Vivo]

LY 233053 (0.5 和 5 mg/kg) 对电惊厥阈值没有影响，但增强了抗癫痫药物的抗惊厥作用[1]。 LY 233053 (5mg/kg) 与卡马西平、二苯基苯妥英或苯巴比妥联合使用可提供 50% 的最大电击保护，但会导致长期记忆损伤[1]。 LY233053 (静脉团注，100mg/kg; 在可逆脊髓缺血后 5、30 或 60 分钟内给药) 对限制缺血性损伤是有效的，但如果在新西兰大白兔损伤后 60 分钟内不开始治疗，保护作用就会丧失[2]。

[References]

[1]. 1.K K Borowicz, et al. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Epilepsia. 1996 Jul;37(7):618-24.

[2]. K P Madden, et al. Efficacy of LY233053, a competitive glutamate antagonist, in experimental central nervous system ischemia. J Neurosurg. 1992 Jan;76(1):106-10.

Chemical & Physical Properties

[ Density]:
1.398g/cm3

[ Boiling Point ]:
488.9ºC at 760mmHg

[ Molecular Formula ]:
C₈H₁₃N₅O₂

[ Molecular Weight ]:
211.22

[ Flash Point ]:
249.5ºC

[ Exact Mass ]:
211.10700

[ PSA ]:
103.79000

[ Vapour Pressure ]:
2.25E-10mmHg at 25°C

[ Index of Refraction ]:
1.581

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.